Trial Profile
A Randomized, Double-Blind Phase I Study to Evaluate Topically Applied WBI-1001 Cream in Patients With Psoriasis.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Oct 2014
Price :
$35
*
At a glance
- Drugs Tapinarof (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Welichem Biotech
- 30 Oct 2014 New trial record